LGC Genomics LLC

Alexandria, MN

UEI
M6S3BJC3LFX8
CAGE
4MSM4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3600 Minnesota St, Alexandria, MN 56308, USA
Founded
1993
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $69,089
FY2025 $0
FY2024 $318,887
FY2023 $118,648

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Agriculture $69,089

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Similar vendors

About the company

LGC Genomics LLC, a foreign-owned for-profit genomics company headquartered in Alexandria, Minnesota, supplies high-throughput DNA extraction equipment, genotyping reagents, and laboratory genomic services to the Department of Agriculture's Agricultural Research Service as a prime contractor on firm fixed-price purchase orders and cooperative agreements, competing under unrestricted full-and-open (non-set-aside) procurement without participation in federal contract vehicles or IDVs.

The vendor's federal footprint centers narrowly on USDA ARS plant science and agricultural genetics programs. The Department of Agriculture accounts for approximately 89% of combined potential value across 110 total awards, with the USDA ARS Field Research Implementation and Information Delivery program representing the dominant customer (53 awards, $956 thousand combined potential value). Within that umbrella, three regional ARS entities — Plains Area (15 awards, $673 thousand), Pacific West Area (7 awards, $104 thousand), and Midwest Area (9 awards, $104 thousand) — drive sustained demand. The National Institute of Diabetes and Digestive and Kidney Diseases (NIH/DHHS) represents a secondary customer (9 awards, $66 thousand) with apparent biotechnology research collaboration. The vendor operates exclusively as a prime contractor; no subcontract footprint exists in the source.

LGC Genomics' capability portfolio is product-centric and specialized. The vendor manufactures and services the oKtopure high-throughput DNA extraction robot — a magnetic bead-based automated platform processing 8 × 96-well plates of DNA samples within four hours with walk-away operation — along with customized sbeadex DNA extraction kits, KASP genotyping assay reagents, robotic pipetting consumables, and probe-based capture sequencing for plant genotyping. Representative awards include a $147.9 thousand firm fixed-price purchase order (July 2024, USDA ARS Southeast Area) for an oKtopure Gen 2 system with consumables; a $129.5 thousand firm fixed-price contract (May 2026, USDA ARS Plains Area) for premier technical support, on-site maintenance, remote support with two-hour business-hours response, and unlimited operator training on an existing oKtopure system extending through April 2031 with four optional one-year renewals; and a $75.4 thousand purchase order (September 2026, USDA ARS Central Program Planning Coordination and Support) for annual oKtopure service and maintenance through September 2029 with two one-year options. The vendor also performs capture-seq sample preparation and sequencing — a $21.0 thousand award (August 2024, USDA ARS Pacific West Area) genotyped 163 blueberry DNA samples using 40,000 probes to identify genes associated with organic acid and polyphenol traits — and supplies standalone reagents and consumables. Repair and calibration services appear in the portfolio as secondary work (e.g., $36.8 thousand for oKtopure system repair, February 2023, USDA ARS Pacific West Area).

Award velocity has contracted in recent years — five awards in 2021 declining to three in both 2024 and 2026 — yielding $2.2 million combined potential value across 110 total awards since 2007, with $1.9 million (90%) obligated. Only one award ($20 thousand) reaches ultimate completion within the next twenty-four months, creating minimal near-term recompete exposure. The vendor holds a single named federal grant: a cooperative agreement with USDA ARS Central Program Planning Coordination and Support for development and implementation of genotyping-by-sequencing (GBS) and SNP tools for tropical plant genotyping, running through June 2027. The top NAICS categories are Research and Development in Biotechnology (43 awards) and Analytical Laboratory Instrument Manufacturing (28 awards); top PSC codes align with Laboratory Equipment and Supplies (52 awards) and maintenance/repair of laboratory equipment (14 awards).

Quick answers

Is LGC Genomics LLC registered in SAM.gov?

Yes. LGC Genomics LLC's SAM.gov registration is active through February 13, 2027.

How much has LGC Genomics LLC received in federal contracts?

Federal contracts obligated $506,624 to LGC Genomics LLC in fiscal years 2023 through 2027.

What is LGC Genomics LLC's most recent federal award?

LGC Genomics LLC's most recent federal contract award is Oktopure high throughput DNA extraction robot premier service contract (12RADA26P0003), from Washington Office (RHS), on September 30, 2026.

On GovTribe

See LGC Genomics LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors